Kolon Life Science’s Invossa Inj to achieve 1,500 procedures
Kolon Life Science(CEO Woo-Seok Lee) announced they acquired approval of Invossa on July 2017, started to sell the product on November and achieved more than 1,500 procedures to July 2018 for 9 months.
According to the company, they spent most of their time in getting recognized for Invossa’s sa...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.